![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H19NO3S |
Molar mass | 305.39 g·mol−1 |
3D model (JSmol) | |
| |
|
GSK137647A (also called GSK137647) is an experimental drug which acts as a highly selective and moderately potent agonist for the free fatty acid receptor FFAR4 (GPR120). [1] It has antiinflammatory effects [2] and has been used to research the role of FFAR4 in various processes such as diabetes, [3] [4] ulcerative colitis, [5] maintenance of bone density, [6] and cancer. [7]